Biopharmaceutical leader in the development of treatments for rare diseases
Educated staff about access to therapies for rare diseases. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.
Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Education about the value of innovative new medicines.H.R. 1281: Newborn Screening Saves Lives Reauthorization Act of 2014.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX